Past investments

• Zeltiq Aesthetics
• BARRX Medical
• The CORE Institute
• Lassen Therapeutics
• Zavante Therapeutics
• Calistoga Pharmaceuticals
• Chimerix
• Alnara Pharmaceuticals
• Nuon Therapeutics
• Stemgent
• Moximed
• Incline Therapeutics
• VentiRx Pharmaceuticals
• Calibra Medical
• Mirum Pharmaceuticals
• Intradigm Corporation
• Tarsus Pharmaceuticals
• Alpine Immune Sciences
• Aptinyx
• Alcresta
• Barosense
• Silvergate Pharmaceuticals
• Dascena
• Cirius Therapeutics
• Outpost Medicine
• Rempex Pharmaceuticals
• Aspen Neuroscience
• Collegium Pharmaceutical
• Seraxis
• Calibrium
• Mavupharma
• Inipharm
• Sierra Oncology
• PatientKeeper
• Kalidex Pharmaceuticals
• AcertaPharma
• Merganser Biotech
• AnaptysBio
• Sojournix
• Iovance Biotherapeutics
• Portola Pharmaceuticals
• EBR Systems
• Imago BioSciences
• MBX Biosciences
• Vaxcyte
• Primaeva Medical
• Millendo Therapeutics
• Clovis Oncology
• Achaogen
• Scout Bio
• Cadence Pharmaceuticals
• Passage Bio
• Recida Therapeutics
• Amunix
• Phathom Pharmaceuticals
• Lengo Therapeutics
• Tobira Therapeutics
• PowerVision
• Calypso Medical
• Cidara Therapeutics
• Semnur Pharmaceuticals
• CVRx
• Gritstone Oncology
• Glaukos
• PreCision Dermatology
• Threshold Pharmaceuticals
• Iterum Therapeutics
• Alteon Health
• Arcutis Biotherapeutics
• Entasis Therapeutics
• Allena Pharmaceuticals
• Laguna Pharmaceuticals